{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:49:31Z","timestamp":1781304571788,"version":"3.54.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14370","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:43:57Z","timestamp":1711626237000},"source":"Crossref","is-referenced-by-count":7,"title":["Assessment and prognostic significance of a serum cytokine panel in diffuse large B\u2011cell lymphoma"],"prefix":"10.3892","volume":"27","author":[{"given":"Shufang","family":"Xie","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Cancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[{"name":"Cancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmao","family":"Ni","sequence":"additional","affiliation":[{"name":"Cancer Center, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"key20240412092030_b1-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1182\/blood-2016-10-744292","article-title":"Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: A lymphoma study association report","volume":"129","author":"Tout","year":"2017","journal-title":"Blood"},{"key":"key20240412092030_b2-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1373\/49.6.1000","article-title":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum","volume":"49","author":"T\u00e1rnok","year":"2003","journal-title":"Clin Chem"},{"key":"key20240412092030_b3-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbamcr.2015.09.018","article-title":"Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression","volume":"1863","author":"Malaponte","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"key20240412092030_b4-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4143\/crt.2014.266","article-title":"Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the effect of host status, tumor burden, and inflammatory activity on venous thromboembolism","volume":"48","author":"Lim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"key20240412092030_b5-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.blre.2017.02.005","article-title":"How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma","volume":"31","author":"Falduto","year":"2017","journal-title":"Blood Rev"},{"key":"key20240412092030_b6-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"key20240412092030_b7-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.leukres.2017.05.014","article-title":"High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma","volume":"59","author":"Dlouhy","year":"2017","journal-title":"Leuk Res"},{"key":"key20240412092030_b8-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"49757","DOI":"10.18632\/oncotarget.17693","article-title":"Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"key20240412092030_b9-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"e10576","DOI":"10.15252\/emmm.201910576","article-title":"The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma","volume":"11","author":"Hashwah","year":"2019","journal-title":"EMBO Mol Med"},{"key":"key20240412092030_b10-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20240412092030_b11-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: A comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"key20240412092030_b12-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"650","DOI":"10.6004\/jnccn.2019.0029","article-title":"NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019","volume":"17","author":"Zelenetz","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"key20240412092030_b13-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/cam4.714","article-title":"Machine learning-based classification of diffuse large B-cell lymphoma patients by eight gene expression profiles","volume":"5","author":"Zhao","year":"2016","journal-title":"Cancer Med"},{"key":"key20240412092030_b14-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"901207","DOI":"10.3389\/fcell.2022.901207","article-title":"Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"key20240412092030_b15-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20240412092030_b16-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00280-008-0685-y","article-title":"Th1\/Th2 balance: An important indicator of efficacy for intra-arterial chemotherapy","volume":"62","author":"Nagai","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20240412092030_b17-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"12351","DOI":"10.18632\/oncotarget.24033","article-title":"Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: A meta-analysis","volume":"9","author":"Peng","year":"2018","journal-title":"Oncotarget"},{"key":"key20240412092030_b18-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"key20240412092030_b19-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1038\/bcj.2015.56","article-title":"IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low\/-) monocytes in B-cell non-Hodgkin lymphoma","volume":"5","author":"Xiu","year":"2015","journal-title":"Blood Cancer J"},{"key":"key20240412092030_b20-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/carcin\/bgl200","article-title":"Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin Lymphoma Study","volume":"28","author":"Purdue","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20240412092030_b21-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1158\/1078-0432.CCR-08-1588","article-title":"Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy","volume":"15","author":"Park","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20240412092030_b22-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/ejh.12139","article-title":"Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen","volume":"91","author":"Nakamura","year":"2013","journal-title":"Eur J Haematol"},{"key":"key20240412092030_b23-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/PAS.0000000000000094","article-title":"TNF-\u03b1 expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified","volume":"38","author":"Nakayama","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20240412092030_b24-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: Molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"key20240412092030_b25-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ijc.33873","article-title":"The effects of TNF-\u03b1\/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer","volume":"150","author":"Qu","year":"2022","journal-title":"Int J Cancer"},{"issue":"(Pt 9)","key":"key20240412092030_b26-ol-27-5-14370","first-page":"1969","article-title":"BAL1\/ARTD9 represses the anti-proliferative and pro-apoptotic IFN\u04af-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma","volume":"126","author":"Camicia","year":"2013","journal-title":"J Cell Sci"},{"key":"key20240412092030_b27-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"key20240412092030_b28-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.V97.1.256","article-title":"Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome","volume":"97","author":"Fayad","year":"2001","journal-title":"Blood"},{"key":"key20240412092030_b29-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1751-553X.2007.00951.x","article-title":"Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma","volume":"30","author":"Nacinovic-Duletic","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"key20240412092030_b30-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00000421-200212000-00007","article-title":"Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma","volume":"25","author":"Aydin","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"key20240412092030_b31-ol-27-5-14370","first-page":"669","article-title":"Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma","volume":"10","author":"Guney","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20240412092030_b32-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1034\/j.1600-0609.2002.01609.x","article-title":"Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma","volume":"68","author":"Niitsu","year":"2002","journal-title":"Eur J Haematol"},{"key":"key20240412092030_b33-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/10428199709051774","article-title":"Interleukin-10 in non-Hodgkin's lymphoma","volume":"26","author":"Cortes","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"key20240412092030_b34-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12032-021-01504-y","article-title":"The role of interleukins and the widely studied TNF-\u03b1 in non-Hodgkin's lymphoma","volume":"38","author":"D'Mello","year":"2021","journal-title":"Med Oncol"},{"key":"key20240412092030_b35-ol-27-5-14370","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4274\/tjh.2013.0325","article-title":"Are the high serum interleukin-6 and vascular endothelial growth factor levels useful prognostic markers in aggressive non-hodgkin lymphoma patients?","volume":"32","author":"Uskudar Teke","year":"2015","journal-title":"Turk J Haematol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:20:38Z","timestamp":1712902838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,28]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14370","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"article-number":"237"}}